Drug intelligence / Profile preview

Epi SP

Development stage: Preclinical
Lead developer: EpiPharm
Modality: Small Molecules
Administration: Topical

Overview

Epi SP is a topical dermato-cosmetic cream currently in preclinical development by the Swiss biotechnology company EpiPharm. The product is being developed for the treatment of various skin disorders. As a dermato-cosmetic, Epi SP is positioned as a therapeutic skincare solution that combines cosmetic properties with dermatological efficacy. Specific details regarding the active ingredients, molecular targets, or the precise mechanism of action have not been disclosed by EpiPharm as of the current development stage.

Brand names: Epi SP cream

Beyond the preview

Go deeper on Epi SP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epi SP.

Explore the full profile